Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;8(2):206.
doi: 10.17303/jcrto.2020.8.206. Epub 2020 Dec 29.

Endometriosis: A Malignant Fingerprint

Affiliations

Endometriosis: A Malignant Fingerprint

Christopher DeAngelo et al. J Cancer Res Ther Oncol. 2020 Apr.

Abstract

Background: Endometriosis is complex, but identifying the novel biomarkers, inflammatory molecules, and genetic links holds the key to the enhanced detection, prediction and treatment of both endometriosis and endometriosis related malignant neoplasia. Here we review the literature relating to the specific molecular mechanism(s) mediating tumorigenesis arising within endometriosis.

Methods: Guidance (e.g. Cochrane) and published studies were identified. The Published studies were identified through PubMed using the systematic review methods filter, and the authors' topic knowledge. These data were reviewed to identify key and relevant articles to create a comprehensive review article to explore the molecular fingerprint associated with in endometriosis-driven tumorigenesis.

Results: An important focus is the link between C3aR1, PGR, ER1, SOX-17 and other relevant gene expression profiles and endometriosis-driven tumorigenesis. Further studies should also focus on the combined use of CA-125 with HE-4, and the role for OVA1/MIA as clinically relevant diagnostic biomarkers in the prediction of endometriosis-driven tumorigenesis.

Conclusions: Elucidating endometriosis' molecular fingerprint is to understand the molecular mechanisms that drive the endometriosis-associated malignant phenotype. A better understanding of the predictive roles of these genes and the value of the biomarker proteins will allow for the derivation of unique molecular treatment algorithms to better serve our patients.

Keywords: endometriosis; gynecologic malignancy; molecular malignant fingerprint; tumorigenesis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors declare no conflicts of interest.

References

    1. Nezhat C, King LP, Paka C, Odegaard J, Beygui R. Bilateral thoracic endometriosis affecting the lung and diaphragm. JSLS. 2012;16(1):140–142. doi:10.4293/108680812X13291597716384 - DOI - PMC - PubMed
    1. Fuldeore M,J, Soliman A,M: Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest 2017;82:453–461. doi: 10.1159/000452660 - DOI - PubMed
    1. Kvaskoff M, Horne AW, Missmer SA. Informing women with endometriosis about ovarian cancer risk. Lancet, 390 (2017), pp. 2433–2434, 10.1016/S0140-6736(17)33049-0 - DOI - PubMed
    1. Eisenberg Vered H., Weil Clara, Chodick Gabriel, Shalev Varda. Epidemiology of endometriosis: a large population-based database study in a 2-million-member health care provider. BJOG. 2017 Apr 26 Published online 2017. April 26. doi: 10.1111/1471-0528.14711 - DOI - PubMed
    1. Morassutto C, Monasta L, Ricci G, Barbone F, & Ronfani L (2016). Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study. PloS one, 11(4), e0154227. doi:10.1371/journal.pone.0154227 - DOI - PMC - PubMed